2011 related articles for article (PubMed ID: 19724015)
1. The role of voriconazole in the treatment of central nervous system blastomycosis.
Ta M; Flowers SA; Rogers PD
Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015
[TBL] [Abstract][Full Text] [Related]
2. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
Panicker J; Walsh T; Kamani N
Pediatr Infect Dis J; 2006 Apr; 25(4):377-9. PubMed ID: 16567998
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of persons with blastomycosis involving the central nervous system.
Bush JW; Wuerz T; Embil JM; Del Bigio MR; McDonald PJ; Krawitz S
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):175-81. PubMed ID: 23566338
[TBL] [Abstract][Full Text] [Related]
4. Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America.
Chapman SW; Bradsher RW; Campbell GD; Pappas PG; Kauffman CA
Clin Infect Dis; 2000 Apr; 30(4):679-83. PubMed ID: 10770729
[TBL] [Abstract][Full Text] [Related]
5. Unilateral Blastomyces dermatitidis optic neuropathy case report and systematic literature review.
Pariseau B; Lucarelli MJ; Appen RE
Ophthalmology; 2007 Nov; 114(11):2090-4. PubMed ID: 17686521
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of cerebral blastomycosis with voriconazole.
Bakleh M; Aksamit AJ; Tleyjeh IM; Marshall WF
Clin Infect Dis; 2005 May; 40(9):e69-71. PubMed ID: 15825017
[TBL] [Abstract][Full Text] [Related]
7. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era.
Bariola JR; Perry P; Pappas PG; Proia L; Shealey W; Wright PW; Sizemore JM; Robinson M; Bradsher RW
Clin Infect Dis; 2010 Mar; 50(6):797-804. PubMed ID: 20166817
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system blastomycosis clinical characteristics and outcomes.
Majdick K; Kaye K; Shorman MA
Med Mycol; 2021 Jan; 59(1):87-92. PubMed ID: 32470976
[TBL] [Abstract][Full Text] [Related]
9. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen.
Borgia SM; Fuller JD; Sarabia A; El-Helou P
Med Mycol; 2006 Nov; 44(7):659-64. PubMed ID: 17071562
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
11. Therapy of blastomycosis.
Bradsher RW
Semin Respir Infect; 1997 Sep; 12(3):263-7. PubMed ID: 9313298
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary blastomycosis diagnosed in Hawai'i.
Arnett MV; Fraser SL; Grbach VX
Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):701-5. PubMed ID: 19058609
[TBL] [Abstract][Full Text] [Related]
14. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J
J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with voriconazole of fungal cerebral abscess due to Cladophialophora bantiana.
Lyons MK; Blair JE; Leslie KO
Clin Neurol Neurosurg; 2005 Oct; 107(6):532-4. PubMed ID: 16202830
[TBL] [Abstract][Full Text] [Related]
17. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
18. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP
Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole in the treatment of fungal eye infections: a review of current literature.
Hariprasad SM; Mieler WF; Lin TK; Sponsel WE; Graybill JR
Br J Ophthalmol; 2008 Jul; 92(7):871-8. PubMed ID: 18577634
[TBL] [Abstract][Full Text] [Related]
20. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
